Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Prometheus (Series of Drugs)

M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A series of drugs. The medicine is helpful for treatment of allergy, anaemia, inflammation, thyroid, tumor and infectious disease.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • 9410 Carroll Park Drive
  • San Diego, CA 92121
  • United States

Prometheus (Series of Drugs) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Prometheus (Series of Drugs)‘s full profile, request access.

Request full access to PitchBook

Prometheus (Series of Drugs) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Prometheus (Series of Drugs)‘s full profile, request access.

Request full access to PitchBook